Using FUS induced BBB/BTB-opening technique combined with Doxorubicin liposomes to improve glioma-targeted inhibition

Ying-Zheng Zhao; Li-Juan Chen; Qian Lin; Jun Cai; Wen-Ze Yu; Ya-Ping Zhao; Chong-Yong Xu; Kai-Li Mao; Fu-Rong Tian; Wen-Feng Li; Ho Lun Wong; Cui-Tao Lu

doi:10.18632/oncotarget.5144

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Withdrawal Notice

This paper was originally published in Oncotarget Advance Online Publications on 09/02/2015.
In compliance with Oncotarget's withdrawal policy, the paper was withdrawn in its entirety. It will not appear in Oncotarget internal or any external indexes or archives.

Advance Publications: Research Papers:

Using FUS induced BBB/BTB-opening technique combined with Doxorubicin liposomes to improve glioma-targeted inhibition

Ying-Zheng Zhao, Li-Juan Chen, Qian Lin, Jun Cai, Wen-Ze Yu, Ya-Ping Zhao, Chong-Yong Xu, Kai-Li Mao, Fu-Rong Tian, Wen-Feng Li, Ho Lun Wong _ and Cui-Tao Lu

Ying-Zheng Zhao1,2,3, Li-Juan Chen4, Qian Lin1, Jun Cai5, Wen-Ze Yu1, Ya-Ping Zhao2, Chong-Yong Xu2, Kai-Li Mao1, Fu-Rong Tian1, Wen-Feng Li6, Ho Lun Wong7, Cui-Tao Lu1,2

1College of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang Province 325035, China

2The Second Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China

3Hainan Medical College, Haikou City, Hainan Province 570102, China

4Dispensary of Traditional Chinese Medicine, Wenzhou Central Hospital, Wenzhou, Zhejiang Province 325000, China

5Departments of Pediatrics and Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky 40202, USA

6The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province 325000, China

7School of Pharmacy, Temple University, Philadelphia, Pennsylvania 19140, USA

Correspondence to:

Ho Lun Wong, e-mail: [email protected]

Cui-Tao Lu, e-mail: [email protected]

Keywords: chemotherapy, focused ultrasound, nanotechonology, BBB opening, glioma

Received: July 09, 2015 Accepted: August 20, 2015 Published: September 02, 2015

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5144

Publication Alerts

Post-Publication Promotion

Withdrawal Notice

Advance Publications: Research Papers:

Using FUS induced BBB/BTB-opening technique combined with Doxorubicin liposomes to improve glioma-targeted inhibition